Johnson & Johnson could turn from backward to winner in the race for global vaccine production from COVID-19

News

Johnson & Johnson could turn from backward to winner in the race for global vaccine production from COVID-19

13.08.2020 News

Johnson & Johnson was one of the first companies to devote large resources to the fight against COVID-19 and vaccine development, and was one of the first to receive support from the US government.

However, J&J is not currently one of the companies, who conducting clinical trials of its final vaccine candidates COVID-19 in humans. Among others, the leaders are now companies such as Pfizer and BioNTech, Moderna.

However, J&J is the world’s largest medical company with a huge resource, and its candidate for the COVID-19 vaccine, according to current data, has more privileges that can make it the biggest winner of all.

Johnson & Johnson may offer only one dose for strong immunity

J&J published on July 30 the results of a preclinical study of the leading candidate for the vaccine “Ad26.COV2-S”, on primates, they showed the formation of strong immune responses from the viral growths of high levels of neutralizing antibodies, which can be infected with coronavirus.

Particularly optimistic is that a strong immune suppressor primates took after a single dose of vaccine. although the company plans to include both single and double dosing in their planned studies in humans, chances are that it can confirm the effectiveness of a single injection of the vaccine. Potentially it may be cheaper and acceptable for government vaccination programs.

In addition to more potential priority of a single-dose approach, J&J also intends to charge a much lower fee for the vaccine than its main competitors.

Last week, J&J signed a deal with the US government to supply 100 million doses of Ad26.COV2-S for about $ 1 billion. By comparison, Pfizer and BioNTech will ship 100 million doses to the United States almost twice as expensive – $ 1.9 billion.

Lower prices with fewer doses may seem like an unwise strategy, however, experts are asking investors not to “write off J&J from the accounts” because, according to epidemiologists, COVID-19 can still “live” on our land for a long time. There is a high probability that vaccination against COVID-19 may be the same procedure as the traditional annual vaccination against influenza.

In the current environment, while continuing pandemic, J & J, probably will sell it at cost. A disposable, inexpensive vaccine from a world-renowned company can be very attractive to governments around the world. This can create good publicity for the vaccine and the potential for sales at a higher price later when added to the traditional annual vaccination calendar.

Investors will learn more about Johnson & Johnson’s Ad26.COV2-S vaccine in September, when the company moves to a later stage of the study.

Other articles

  • The first batch of Pfizer COVID vaccine has arrived in Israel
    News

    The first batch of Pfizer COVID vaccine has arrived in Israel

    The first batch of Pfizer coronavirus vaccine has been delivered to Israel. This was reported by The Jerusalem Post on Wednesday, December 9. “A DHL flight from Brussels carried more than 100,000 doses of the newly created vaccine and landed at Ben Gurion Airport in Tel Aviv around 9 a.m.,” the statement said. The doses […]

  • Pfizer will deliver half of the planned number of vaccines in 2020
    News

    Pfizer will deliver half of the planned number of vaccines in 2020

    Shares of Pfizer and BioNTech fell 1.74% and 2% (respectively) on Thursday amid news that companies will deliver half of their planned number of vaccines against COVID-19 in 2020. On November 20, Pfizer and its German partner BioNTech applied to the FDA (US Food and Drug Administration) for permission to use their vaccine in an […]

  • US pharmaceutical giant Pfizer will open a new hub in Greece
    News

    US pharmaceutical giant Pfizer will open a new hub in Greece

    American Pfizer is one of the world’s largest pharmaceutical companies. Greek government spokesman Stelios Petsas stated it’s expanding its presence in Greece, creating 600 workplaces. Pfizer’s chairman is Greek Albert Burla. In recent months, the company has been developing a vaccine against coronavirus. A company hub opens in Thessaloniki. “Greece is attracting big investment and […]

  • Gucci to donate half a million dollars to UNICEF for vaccination against COVID-19
    News

    Gucci to donate half a million dollars to UNICEF for vaccination against COVID-19

    The most popular fashion brand Gucci will donate about $ 500,000 for the purchase and distribution of a new type of coronavirus vaccine among vulnerable people around the world. It is noted that the funds will be transferred to UNICEF, which supports the WHO initiative on mass vaccination COVAX and the GAVI group. “Global equitable […]

  • Lufthansa has announced large-scale job-cuts
    News

    Lufthansa has announced large-scale job-cuts

    By the end of this year, the German airline Lufthansa intends to reduce its foreign staff by 20 thousand people, as well as sell its LSG division, which deals with on-board catering, which employs 7.5 thousand people. Lufthansa subsidiaries Eurowings, Swiss, Austrian and Brussels Airlines are reducing the frequency of flights, fleets and staff amid […]

  • Johnson & Johnson plans to complete the third phase of trials of the COVID-19 vaccine in January
    News

    Johnson & Johnson plans to complete the third phase of trials of the COVID-19 vaccine in January

    Johnson & Johnson plans to complete the third phase of trials of its single-dose vaccine against COVID-19 in mid-January 2021. Paul Stoffels, vice chairman of the executive committee, senior scientific expert at Johnson & Johnson said they plan to deliver to market 1 billion doses. “We are in the middle of the third phase of […]

  • Moderna vaccine will be tested on teenagers
    News

    Moderna vaccine will be tested on teenagers

    The mRNA-1273 vaccine from the American company Moderna will be tested on three thousand children in six US states. CNN reported this on Wednesday, December 2. “Moderna has started inviting children over the age of 12 to try the vaccine” the statement said. It is noted that the study will involve volunteers aged 12-18 from […]

  • Moderna has reported 100% efficiency of the vaccine against severe cases of COVID-19
    News

    Moderna has reported 100% efficiency of the vaccine against severe cases of COVID-19

    Following the third phase of trials of its COVID-19 coronavirus vaccine, Moderna said the drug was generally well tolerated and no serious health problems were identified. According to the company, the effectiveness of its vaccine reaches 94.1%, and 100% for preventing severe coronavirus cases. Previously, the manufacturer estimated the effectiveness of its drug at 94.5%. […]

Read also

Johnson & Johnson could turn from backward to winner in the race for global vaccine production from COVID-19
News

Italy starts antitrust investigation against Apple, Google and Dropbox

The Italian Antimonopoly Authority has announced that investigating allegations of fairness and improper commercial practices of Apple’s cloud services, Google and Dropbox. Along with the recent investigation into alleged fixing of prices, Italy’s antitrust regulator has said, that separately examines how companies, including Apple, manage their business in the cloud services in the country. According […]

Next
Johnson & Johnson could turn from backward to winner in the race for global vaccine production from COVID-19
News

Adidas may sell Reebok

According to Bloomberg, a source familiar with the situation, German manufacturer of sportswear and accessories Adidas AG is considering the possibility of selling its brand Reebok. “In the coming months, the company will decide whether to start the sale process,” the source said. According to the interlocutor of the agency, the internal assessment of sales […]

Next
Johnson & Johnson could turn from backward to winner in the race for global vaccine production from COVID-19
News

Elektrovazhmash will modernize Ukrzaliznytsia’s locomotives

Kharkiv plant Electrovazhmash will soon receive a certificate and will participate in tenders of Ukrzaliznytsia for the renewal of rolling stock. This was announced on Thursday, March 25, the State Property Fund. Representatives of the companies discussed further cooperation within the framework of the previously signed road map. The Minister of Infrastructure Vladislav Krykliy and […]

Next
Johnson & Johnson could turn from backward to winner in the race for global vaccine production from COVID-19
News

“GSK” and “Vir Biotechnology” go to phase of the 3 studies of antibodies against COVID-19

Companies Vir Biotechnology, Inc. and GlaxoSmithKline plc (GSK) announced the global extension to phase 3 of the COMET-ICE study, which evaluates the effectiveness of monoclonal antibodies – VIR-7831 for early treatment of COVID-19 in patients at high risk of hospitalization. VIR-7831 (also known as GSK4182136) is the fully human monoclonal antibody against SARS-CoV-2, selected for […]

Next
Johnson & Johnson could turn from backward to winner in the race for global vaccine production from COVID-19
News

Ukrainian IT-company GOS Systems enters the world market

In 2015, the Ukrainian IT – industry has proved to be one of the most profitable invested by the West. Despite the difficult economic and political processes in the country, the domestic business is developing and coming out to the world market. Recently, the domestic company GOS Systems reported that it launches the project in […]

Next
Johnson & Johnson could turn from backward to winner in the race for global vaccine production from COVID-19
News

Shares of US tech giants appeared on the Ukrainian stock exchange PFTS

Shares of large American technology companies – Microsoft, AMD, Visa, Tesla, Netflix and Facebook – have been admitted to trading on the Ukrainian stock exchange PFTS. This was reported by the press service of the exchange. According to the results of April 15, the quotations (best bid) of the mentioned shares are as follows: Microsoft […]

Next
Johnson & Johnson could turn from backward to winner in the race for global vaccine production from COVID-19
News

AT&T’s quarterly revenues exceeded estimates after adding 645,000 new telephone subscribers

Shares of AT&T, which have lost 27.6% of value since the beginning of the year, rose up to 5.8% on Thursday after the publication of better-than-expected Wall Street analysts, earnings for the 3rd quarter, which ended on September 30. AT&T reported earnings per share of $ 0.76, which is 19% below last year’s value, but […]

Next
Johnson & Johnson could turn from backward to winner in the race for global vaccine production from COVID-19
News

Buffett’s company increased a quarterly net profit to 87%

The investment company of billionaire Warren Buffett’s Berkshire Hathaway in the II quarter 2020 net income increased due to higher cost of investment after the rise of stock markets and the collapse in the first quarter due to coronavirus pandemic. During the reporting period the company received $ 26.3 billion in net profit to $ […]

Next
Johnson & Johnson could turn from backward to winner in the race for global vaccine production from COVID-19
News

Converse sells shoes on the garbage island

The Converse brand has opened a virtual store on a garbage island in the Pacific Ocean, which consists of 80,000 tons of plastic and is larger than the area of ​​France. The offers of this outlet can be found on the store’s website. It is reported that the Renew Labs space was developed by Virtue. […]

Next
Johnson & Johnson could turn from backward to winner in the race for global vaccine production from COVID-19
News

Eli Lilly and Regeneron have requested the permission for the emergency use of drugs from COVID-19

Eli Lilly and Regeneron have applied to the Food and Drug Administration (FDA) for the permission to use emergency coronavirus drugs. Eli Lilly conducted clinical trials with the placebo group, as a result of which the drug has proven its antiviral action. Regeneron did not provide the research data, but the company’s drug was widely […]

Next
Johnson & Johnson could turn from backward to winner in the race for global vaccine production from COVID-19
News

S&P знизило рейтинг України до переддефолтного

Агентство S&P Global Ratings знизило довгостроковий суверенний рейтинг України в іноземній валюті із CCC+ до CC. Переддефолтний рейтинг у зв’язку з рішенням Кабміну просити бондхолдерів про відстрочку виплат за всіма зовнішніми зобов’язаннями на 24 місяці. Така реструктуризація, за оцінкою S&P, є рівнозначною дефолту. S&P Global Ratings не виключає, що знизить рейтинг до SD (вибірковий дефолт) […]

Next
Johnson & Johnson could turn from backward to winner in the race for global vaccine production from COVID-19
News

The government has partially lifted the moratorium on tax audits of businesses

The Cabinet of Ministers of Ukraine has shortened the moratorium on certain types of tax inspections. The Cabinet of Ministers of Ukraine has shortened the moratorium on certain types of tax inspections. The press service of the Ministry of Finance announced this on Wednesday, February 3, citing a relevant government decree. According to the document, […]

Next
Johnson & Johnson could turn from backward to winner in the race for global vaccine production from COVID-19
News

Tesla plans to produce the Model Y with the new technology battery at the plant in Berlin

Shares of Tesla rose by 2.73% to $ 425.30 on Wednesday amid overall stock index growth, however, this growth was lower than the growth of shares of competitors such as Ford, General Motors and Chinese automaker NIO, which rose by 3.58%, 4% and 4.3% respectively. Tesla’s current share price of $ 77.19 is below the […]

Next
Johnson & Johnson could turn from backward to winner in the race for global vaccine production from COVID-19
News

Pfizer and BioNTech have applied for registration of the COVID-19 vaccine in Europe

The American company Pfizer and the German BioNTech have applied to the European Medicines Agency for registration of their coronavirus vaccine. The announcement was published on the BioNTech website. “On Monday, November 30, Pfizer and BioNTech filed a formal application with the European Medicines Agency for a conditional authorization to use their COVID-19 candidate vaccine […]

Next
Johnson & Johnson could turn from backward to winner in the race for global vaccine production from COVID-19
News

Nika-Tera froze the 40 million UAH investment project

Due to the actions of the prosecutor ‘s office in  Mykolayiv region  the Sea specialized port Nika-Tera has frozen a large investment project of 40 million UAH. At the same time the city budget of  Mykolayiv has lost a considerable amount of lease of the water fund lands. This was stated by the chairman of […]

Next
Johnson & Johnson could turn from backward to winner in the race for global vaccine production from COVID-19
News

The NBU estimated payments on public debt for the year

Over the next 12 months, Ukraine must pay $ 10 billion from its foreign currency debt. This is stated in the June report of the National Bank on financial stability. “Over the next 12 months, only foreign currency payments of the government and the NBU on public and guaranteed debt will exceed $ 10 billion. […]

Next